Adar1 Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $615 Billion distributed in 278 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $48.1B, Protagonist Therapeutics, Inc with a value of $44.2B, Bridge Bio Pharma, Inc. with a value of $36.9B, Ea Series Trust with a value of $35.2B, and Roivant Sciences Ltd. with a value of $34.9B.
Examining the 13F form we can see an increase of $85.2B in the current position value, from $530B to 615B.
Adar1 Capital Management, LLC is based out at Austin, TX
Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$615 Billion
Healthcare: $433 Billion
ETFs: $6.5 Billion
Communication Services: $3.51 Billion
Utilities: $1.26 Billion
Technology: $995 Million
Industrials: $511 Million
Real Estate: $132 Million
Basic Materials: $121 Million
Other: $293 Million
Stock Holdings Table Market Cap. of $50 Millions to $300 Millions
